汇宇制药(688553.SH)拟出资1.5亿元参与设立私募基金

智通财经2025-11-27

智通财经APP讯，汇宇制药(688553.SH)发布公告，公司拟与杭州晓池私募基金管理有限公司(简称“晓池资本”)、成都光华梧桐股权投资基金管理有限公司(简称“光华梧桐”)及其他合伙人共同投资设立成都汇宇晓池生物医疗创业投资合伙企业(有限合伙)，主要投资于生物医疗领域，重点聚焦管线处于临床关键中后期、具备明确商业潜力的投资标的。该私募基金初始认缴规模为4亿元，公司拟作为有限合伙人以自有资金认缴...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2586357243?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-11-27 16:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2586357243","market":"sh","top_or_hot":-1,"title":"汇宇制药(688553.SH)拟出资1.5亿元参与设立私募基金","media":"智通财经","content":"<div>\n<p>智通财经APP讯，汇宇制药(688553.SH)发布公告，公司拟与杭州晓池私募基金管理有限公司(简称“晓池资本”)、成都光华梧桐股权投资基金管理有限公司(简称“光华梧桐”)及其他合伙人共同投资设立成都汇宇晓池生物医疗创业投资合伙企业(有限合伙)，主要投资于生物医疗领域，重点聚焦管线处于临床关键中后期、具备明确商业潜力的投资标的。该私募基金初始认缴规模为4亿元，公司拟作为有限合伙人以自有资金认缴...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1374463.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>汇宇制药(688553.SH)拟出资1.5亿元参与设立私募基金</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n汇宇制药(688553.SH)拟出资1.5亿元参与设立私募基金\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-11-27 16:50 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1374463.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，汇宇制药(688553.SH)发布公告，公司拟与杭州晓池私募基金管理有限公司(简称“晓池资本”)、成都光华梧桐股权投资基金管理有限公司(简称“光华梧桐”)及其他合伙人共同投资设立成都汇宇晓池生物医疗创业投资合伙企业(有限合伙)，主要投资于生物医疗领域，重点聚焦管线处于临床关键中后期、具备明确商业潜力的投资标的。该私募基金初始认缴规模为4亿元，公司拟作为有限合伙人以自有资金认缴...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1374463.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"688553","symbol_name":"汇宇制药","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1374463.html","article_id":"2586357243","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2586357243","pubTimestamp":1764233428,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，汇宇制药(688553.SH)发布公告，公司拟与杭州晓池私募基金管理有限公司(简称“晓池资本”)、成都光华梧桐股权投资基金管理有限公司(简称“光华梧桐”)及其他合伙人共同投资设立成都汇宇晓池生物医疗创业投资合伙企业(有限合伙)，主要投资于生物医疗领域，重点聚焦管线处于临床关键中后期、具备明确商业潜力的投资标的。该私募基金初始认缴规模为4亿元，公司拟作为有限合伙人以自有资金认缴出资额1.5亿元，占初始总认缴规模出资总额的37.50%。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"688553":"汇宇制药","BK0239":"医药制造"},"translate_title":"Huiyu Pharmaceutical (688553. SH) plans to invest 150 million yuan to participate in the establishment of private equity funds","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688553":1.5},"content_text":"智通财经APP讯，汇宇制药(688553.SH)发布公告，公司拟与杭州晓池私募基金管理有限公司(简称“晓池资本”)、成都光华梧桐股权投资基金管理有限公司(简称“光华梧桐”)及其他合伙人共同投资设立成都汇宇晓池生物医疗创业投资合伙企业(有限合伙)，主要投资于生物医疗领域，重点聚焦管线处于临床关键中后期、具备明确商业潜力的投资标的。该私募基金初始认缴规模为4亿元，公司拟作为有限合伙人以自有资金认缴出资额1.5亿元，占初始总认缴规模出资总额的37.50%。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2586357243","isCrawlerRequest":true}